On February 15, 2022 Arcus Biosciences, Inc. (NYSE: RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, reported that management will participate at the following upcoming investor conferences (Press release, Arcus Biosciences, FEB 15, 2022, View Source [SID1234608149]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
SVB Leerink 11th Annual Global Healthcare Conference
Date & Time: Wednesday, February 16th, 2022 at 1:20 p.m. PT
Format: Fireside Chat
Barclay’s Global Healthcare Conference
Date & Time: Thursday, March 17th, 2022 at 1:35 p.m. ET
Format: Fireside Chat
Live audio webcasts will be available by visiting the "Investors & Media" section of the Arcus Biosciences website at www.arcusbio.com. A replay of the webcasts will be available for at least two weeks following the live events.